Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients.
about
Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time.Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies.Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-β-lactamase-producing Escherichia coli.Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities.Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.Occurrence of ESBL-Producing Escherichia coli in Livestock and Farm Workers in Mecklenburg-Western Pomerania, Germany.Colonization with resistant microorganisms in patients transferred from abroad: who needs to be screened?Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France.Prevalence of extended-spectrum beta-lactamase-producing bacteria in foodRisk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli.Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland.Clinical significance of extended-spectrum beta-lactamases.Characterization of integrons among Escherichia coli in a region at high incidence of ESBL-EC.The Efficacy of Isolated Bacteriophages from Pig Farms against ESBL/AmpC-Producing Escherichia coli from Pig and Turkey FarmsThe complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Intense pre-admission carriage and further acquisition of ESBL-producing Enterobacteriaceae among patients and their caregivers in a tertiary hospital in Rwanda.Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.Frequency of extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacilli in a 200-bed multi-specialty hospital in Vellore district, Tamil Nadu, India.Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer.Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.Characterization and Genomic Study of Phage vB_EcoS-B2 Infecting Multidrug-Resistant Escherichia coli.Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation.Dissemination of Multidrug-Resistant, Class I and II Integrons and Molecular Typing of CTX-M-producing Klebsiella pneumoniae.Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipientsExtended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU
P2860
Q33614205-64719152-D7D5-4AF9-B58A-CD96B0715928Q34249389-9F5E7AFF-5F77-40F4-BF30-6FF4D3251FB5Q34597721-56F9007A-96FA-47C2-BC98-84D3EC5AC77CQ34623275-E10D4D0A-7890-4DD8-BAE7-6CF24E47E22AQ35135491-5BA1E3A7-AF86-4CF1-A439-53AA25A82073Q35852382-3CE77354-4449-4185-B7FA-E2CA790CB941Q35888780-C3CAD152-6C48-42CC-B676-4A9DDD7C4C39Q35979859-01066DDB-7605-4852-B6A1-DA82BF8D740DQ36334140-99D43FBC-B50C-49CF-B033-E54C2C2CF113Q36364145-27CC029F-C622-4884-898F-21D48776885DQ37014177-12F56B8A-ADCD-464B-9AB4-60A077F259C1Q37291354-29F1F09A-FF1C-4BAA-904D-7299B7D8460CQ37639669-AE5B4092-295E-46EF-BBA9-779C1828E10CQ37725893-D4765F5F-122A-4468-A926-76577AB22BC6Q38497797-EB8C13BD-78B3-4E6F-8E94-F443B751ED7CQ39115580-AF31D8A1-8C0E-4A0F-B0B5-354676F6A477Q39519393-FFE78254-DE92-460C-B064-AD5E7055DE44Q40032314-28CB8B10-967B-4B5D-AC05-99A196CB8EEFQ40053362-59014D4D-AB3E-4B7C-9A12-4ABA9B87FE43Q41433212-52FA5E70-75DB-46C2-B7EE-B75204293BCDQ43251098-FD483BC4-6C0D-4569-A297-7A6FAB346C3FQ51445786-3A9A10D3-5DF3-4A37-B742-59145B40230AQ54201608-D96CD16E-6174-426C-988B-E45B4A371ADDQ54343215-621FE496-6E7C-49C2-8CC9-C1B1C8B55AE6Q54376284-912A1B11-7BC6-479C-BCED-7F53580AFD3CQ54417710-7A16CF37-BEB4-4C0E-A1A1-3465CF50EA3AQ55234276-65D25257-45C4-4CBD-A809-91811B12EE2FQ56889467-48E02995-E100-4586-96BB-A797F80BE21CQ56925190-7EA96E0E-1C06-43F6-8C8B-1964BF64E6C0Q58704101-B8579B14-6B71-4E60-A9FE-F873CE0579A3
P2860
Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Risk-factors for acquisition o ...... i among hospitalised patients.
@en
Risk-factors for acquisition o ...... i among hospitalised patients.
@nl
type
label
Risk-factors for acquisition o ...... i among hospitalised patients.
@en
Risk-factors for acquisition o ...... i among hospitalised patients.
@nl
prefLabel
Risk-factors for acquisition o ...... i among hospitalised patients.
@en
Risk-factors for acquisition o ...... i among hospitalised patients.
@nl
P2093
P921
P1476
Risk-factors for acquisition o ...... i among hospitalised patients.
@en
P2093
Calatayud L
Dominguez MA
P304
P356
10.1111/J.1469-0691.2005.01358.X
P577
2006-03-01T00:00:00Z